Lannett Co., Inc.
LCI
Market Cap$29.52M
Close$
Share Statistics
| Market cap | $29.52 Million |
|---|---|
| Enterprise Value | $611.37 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-4.72 |
| Beta | 0.95 |
| Outstanding Shares | 43,066,265 |
| Avg 30 Day Volume | 123,125 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.15 |
|---|---|
| PEG | -0.08 |
| Price to Sales | 0.1 |
| Price to Book Ratio | -0.07 |
| Enterprise Value to Revenue | 1.97 |
| Enterprise Value to EBIT | -10.81 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 1.03 |
| Debt to Equity | -1.52 |
Revenue Sources
No data
ESG Score
No data
About Lannett Co., Inc.
564 employees
CEO: Timothy Crew Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications.